» Articles » PMID: 29532980

The Effect of Splenectomy on the Levels of PCV-13-induced Memory B- and T Cells

Overview
Publisher Wiley
Specialty General Medicine
Date 2018 Mar 14
PMID 29532980
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Splenectomised patients are associated with lifelong risk of fatal overwhelming post-splenectomy infection (OPSI), which is mostly caused by Streptococcus pneumoniae. Today OPSI cases can still be reported even in patients with appropriate vaccination. In our study, the levels of vaccine-specific memory B- and T cells were compared between control and splenectomised patients to enlighten the underlying reason.

Materials And Methods: Five healthy and 14 post-traumatic splenectomised individuals were vaccinated with 13-valent pneumococcal conjugate vaccine (PCV-13) followed by 23-valent pneumococcal polysaccharide vaccine (PPV-23). The levels of memory B- and T cells were compared by ELISPOT analysis.

Results: Splenectomised patients generated reduced levels of memory IgG B cells in response to PCV-13 vaccination, while the memory IFN-γ T-cell levels were undetectable in asplenic patients. This was despite the detection of vaccine-induced memory T-cell levels in control patients, which were analysed simultaneously following the same experimental protocol.

Conclusion: Our results suggest that spleen is important, but not essential, for survival and/or generation of memory IgG B cells. In contrast, it seems to be indispensable for PCV-13-specific memory T 1-cell levels. Studies enhancing the levels of vaccine-induced memory cells and further enlightening the immune responses in asplenic individuals are required to develop more effective vaccination strategies against OPSI.

Citing Articles

Case report: Fatal overwhelming post-splenectomy infection in a patient with metastatic angiosarcoma treated with immunotherapy.

Torrado C, Baysal M, Chakraborty A, Norris B, Khawaja F, Tsimberidou A Front Immunol. 2024; 15:1366271.

PMID: 38779675 PMC: 11109375. DOI: 10.3389/fimmu.2024.1366271.


Establishment of an ELISpot Assay to Detect Cellular Immunity against in Vaccinated Kidney Transplant Recipients.

Gackler A, Mulling N, Volk K, Wilde B, Eisenberger U, Rohn H Vaccines (Basel). 2021; 9(12).

PMID: 34960184 PMC: 8706129. DOI: 10.3390/vaccines9121438.